Factors affecting therapeutic compliance: A review from the patient's perspective

Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, Shu Chuen Li, Jing Jin, Grant Edward Sklar, Vernon Min Sen Oh, Shu Chuen Li

Abstract

Objective: To explore and evaluate the most common factors causing therapeutic non-compliance.

Methods: A qualitative review was undertaken by a literature search of the Medline database from 1970 to 2005 to identify studies evaluating the factors contributing to therapeutic non-compliance.

Results: A total of 102 articles was retrieved and used in the review from the 2095 articles identified by the literature review process. From the literature review, it would appear that the definition of therapeutic compliance is adequately resolved. The preliminary evaluation revealed a number of factors that contributed to therapeutic non-compliance. These factors could be categorized to patient-centered factors, therapy-related factors, social and economic factors, healthcare system factors, and disease factors. For some of these factors, the impact on compliance was not unequivocal, but for other factors, the impact was inconsistent and contradictory.

Conclusion: There are numerous studies on therapeutic noncompliance over the years. The factors related to compliance may be better categorized as "soft" and "hard" factors as the approach in countering their effects may differ. The review also highlights that the interaction of the various factors has not been studied systematically. Future studies need to address this interaction issue, as this may be crucial to reducing the level of non-compliance in general, and to enhancing the possibility of achieving the desired healthcare outcomes.

Keywords: adherence; factors; patient compliance.

Figures

Figure 1
Figure 1
Retrieval and culling process of the articles in literature review process.

References

    1. Abbott J, Dodd M, Webb AK. Health perceptions and treatment adherence in adults with cystic fibrosis. Thorax. 1996;51:1233–8.
    1. Alm-Roijer C, Stagmo M, Uden G, et al. Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease. Eur J Cardiovasc Nurs. 2004;3:321–30.
    1. Apter AJ, Reisine ST, Affleck G, et al. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med. 1998;157:1810–7.
    1. Apter AJ, Boston RC, George M. Modifiable barriers to adherence to inhaled steroids among adults with asthma: it’s not just black and white. J Allergy Clin Immunol. 2003;111:1219–26.
    1. Avorn J, Monette J, Lacour A, et al. Persistence of use of lipid-lowering medications: a cross national study. JAMA. 1998;279:1458–62.
    1. Balbay O, Annakkaya AN, Arbak P, et al. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Jpn J Infect Dis. 2005;58:152–8.
    1. Balkrishnan R, Rajagopalan R, Camacho FT, et al. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther. 2003;25:2958–71.
    1. Barnes L, Moss-Morris R, Kaufusi M. Illness beliefs and adherence in diabetes mellitus: a comparison between Tongan and European patients. N Z Med J. 2004;117:U743.
    1. Bartlett EE, Grayson M, Barker R, et al. The effects of physician communications skills on patient satisfaction; recall, and adherence. J Chronic Dis. 1984;37:755–64.
    1. Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin N Am. 2005;25:107–30.
    1. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455–61.
    1. Berghofer G, Schmidl F, Rudas S, et al. Predictors of treatment discontinuity in outpatient mental health care. Soc Psychiatry Psychiatr Epidemiol. 2002;37:276–82.
    1. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm. 1991;48:1978–88.
    1. Bosley CM, Fosbury JA, Cochrane GM. The psychological factors associated with poor compliance with treatment in asthma. Eur Respir J. 1995;8:899–904.
    1. Buck D, Jacoby A, Baker GA, et al. Factors influencing compliance with antiepileptic drug regimes. Seizure. 1997;6:87–93.
    1. Burnier M, Santschi V, Favrat B, et al. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens Suppl. 2003;21:S37–42.
    1. Butterworth JR, Banfield LM, Iqbal TH, et al. Factors relating to compliance with a gluten-free diet in patients with coeliac disease: comparison of white Caucasian and South Asian patients. Clin Nutr. 2004;23:1127–34.
    1. Carney RM, Freedland KE, Eisen SA, et al. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 1995;14:88–90.
    1. Caro JJ, Salas M, Speckman JL, et al. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31–7.
    1. Caspard H, Chan AK, Walker AM. Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia. Clin Ther. 2005;27:1639–46.
    1. Cerkoney KA, Hart LK. The relationship between the health belief model and compliance of persons with diabetes mellitus. Diabetes Care. 1980;3:594–8.
    1. Chan YM, Molassiotis A. The relationship between diabetes knowledge and compliance among Chinese with non-insulin dependent diabetes mellitus in Hong Kong. J Adv Nurs. 1999;30:431–8.
    1. Chizzola PR, Mansur AJ, da Luz PL, et al. Compliance with pharmacological treatment in outpatients from a Brazilian cardiology referral center. Sao Paulo Med J. 1996;114:1259–64.
    1. Choi-Kwon S, Kwon SU, Kim JS. Compliance with risk factor modification: early-onset versus late-onset stroke patients. Eur Neurol. 2005;54:204–11.
    1. Christensen AJ, Smith TW. Personality and patient adherence: correlates of the five-factor model in renal dialysis. J Behav Med. 1995;18:305–13.
    1. Christensen DB. Drug-taking compliance: a review and synthesis. Health Serv Res. 1978;13:171–87.
    1. Chuah SY. Factors associated with poor patient compliance with antituberculosis therapy in Northwest Perak, Malaysia. Tubercle. 1991;72:261–4.
    1. Clark N, Jones P, Keller S, et al. Patient factors and compliance with asthma therapy. Respir Med. 1999;93:856–62.
    1. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296–310.
    1. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273–7.
    1. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509–10.
    1. Cramer JA. Enhancing patient compliance in the elderly. Role of packaging aids and monitoring. Drugs Aging. 1998;12:7–15.
    1. Cochrane GM, Horne R, Chanez P. Compliance in asthma. Respir Med. 1999;93:763–9.
    1. Cockburn J, Gibberd RW, Reid AL, et al. Determinants of non-compliance with short term antibiotic regimens. Br Med J (Clin Res Ed) 1987;295:814–8.
    1. Combs DL, O’Brien RJ, Geiter LJ, et al. Compliance with tuberculosis regimes: results from USPHS therapy trial 21. Am Rev Respir Dis. 1987;135:A138.
    1. Congressional Budget Office. Prescription drug coverage and Medicare’s fiscal challenges. 2003. [online] Accessed on 1 March 2007.URL:
    1. Connelly CE. Compliance with outpatient lithium therapy. Perspect Psychiatr Care. 1984;22:44–50.
    1. Cooper C, Carpenter I, Katona C, et al. The AdHOC study of older adults’ adherence to medication in 11 countries. Am J Geriatr Psychiatry. 2005;13:1067–76.
    1. Cummings KM, Kirscht JP, Binder LR, et al. Determinants of drug treatment maintenance among hypertensive persons in inner city Detroit. Public Health Rep. 1982;97:99–106.
    1. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995;59:340–7.
    1. Degoulet P, Menard J, Vu HA, et al. Factors predictive of attendance at clinic and blood pressure control in hypertensive patients. Br Med J (Clin Res Ed) 1983;287:88–93.
    1. Dhanireddy KK, Maniscalco J, Kirk AD. Is tolerance induction the answer to adolescent non-adherence? Pediatr Transplant. 2005;9:357–63.
    1. Didlake RH, Dreyfus K, Kerman RH, et al. Patient noncompliance: a major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc. 1988;20:63–9.
    1. Dietrich AJ, Oxman TE, Burns MR, et al. Application of a depression management office system in community practice: a demonstration. J Am Board Fam Pract. 2003;16:107–14.
    1. DiMatteo MR. Patient adherence to pharmacotherapy: the importance of effective communication. Formulary. 1995;30:596–8. 601–2, 605.
    1. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23:207–18.
    1. Dominick KL, Golightly YM, Bosworth HB. Racial differences in analgesic/anti-inflammatory medication adherence among patients with osteoarthritis. Ethn Dis. 2005;15:116–22.
    1. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med. 1992;34:507–13.
    1. Dowse R, Ehlers M. Medicine labels incorporating pictograms: do they influence understanding and adherence? Patient Educ Couns. 2005;58:63–70.
    1. Dusing R, Weisser B, Mengden T, et al. Changes in antihypertensive therapy-the role of adverse effects and compliance. Blood Press. 1998;7:313–5.
    1. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881–4.
    1. Ellis JJ, Erickson SR, Stevenson JG, et al. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. J Gen Intern Med. 2004;19:638–45.
    1. Farmer KC, Jacobs EW, Phillips CR. Long-term patient compliance with prescribed regimens of calcium channel blockers. Clin Ther. 1994;16:316–26.
    1. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150:1377–8.
    1. Feinstein S, Keich R, Becker-Cohen R, et al. Is noncompliance among adolescent renal transplant recipients inevitable? Pediatrics. 2005;115:969–73.
    1. Fodor GJ, Kotrec M, Bacskai K, et al. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens. 2005;23:1261–6.
    1. Frazier PA, Davis-Ali SH, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant. 1994;8:550–7.
    1. Garay-Sevilla ME, Nava LE, Malacara JM, et al. Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus. J Diabetes Complications. 1995;9:81–6.
    1. Gascon JJ, Sanchez-Ortuno M, Llor B, et al. Treatment Compliance in Hypertension Study Group. Why hypertensive patients do not comply with the treatment: results from a qualitative study. Fam Pract. 2004;21:125–30.
    1. Ghods AJ, Nasrollahzadeh D. Noncompliance with immunnosuppressive medications after renal transplantation. Exp Clin Transplant. 2003;1:39–47.
    1. Gonzalez J, Williams JW, Jr, Noel PH, et al. Adherence to mental health treatment in a primary care clinic. J Am Board Fam Pract. 2005;18:87–96.
    1. Gordis L. Conceptual and methodologic problem in measuring patient compliance. In: Haynes B, Taylor DW, Sackett DL, editors. Compliance in health care. Baltimore: The John Hopkins University Press; 1979. pp. 23–45.
    1. Grant RW, Devita NG, Singer DE, et al. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–12.
    1. Grunebaum M, Luber P, Callahan M, et al. Predictors of missed appointments for psychiatric consultations in a primary care clinic. Psychiatr Serv. 1996;47:848–52.
    1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199–206.
    1. Hamburg BA, Inoff GE. Relationships between behavioral factors and diabetic control in children and adolescents: a camp study. Psychosom Med. 1982;44:321–39.
    1. Haynes RB, Taylor DW, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension. 1980;2:757–64.
    1. Hernandez-Ronquillo L, Tellez-Zenteno JF, Garduno-Espinosa J, et al. Factors associated with therapy noncompliance in type-2 diabetes patients. Salud Publica Mex. 2003;45:191–7.
    1. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance. Clin Ther. 2005;27:1064–73.
    1. Hope CJ, Wu J, Tu W, et al. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm. 2004;61:2043–9.
    1. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–67.
    1. Hungin AP, Rubin G, O’Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract. 1999;49:463–4.
    1. Iihara N, Tsukamoto T, Morita S, et al. Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication. J Clin Pharm Ther. 2004;29:417–24.
    1. Inkster ME, Donnan PT, MacDonald TM, et al. Adherence to antihypertensive medication and association with patient and practice factors. J Hum Hypertens. 2006;20:295–7.
    1. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60:556–64.
    1. Iskedjian M, Einarson TR, MacKeigan LD, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002;24:302–16.
    1. Jeste SD, Patterson TL, Palmer BW, et al. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res. 2003;63:49–58.
    1. Jette AM, Rooks D, Lachman M, et al. Home-based resistance training: predictors of participation and adherence. Gerontologist. 1998;38:412–21.
    1. Kaona FA, Tuba M, Siziya S, et al. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;29:68.
    1. Kaplan RC, Bhalodkar NC, Brown EJ, Jr, et al. Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med. 2004;39:1249–55.
    1. Kass MA, Meltzer DW, Gordon M, et al. Compliance with topical pilocarpine treatment. Am J Ophthalmol. 1986;101:515–23.
    1. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Intern Med. 1994;154:1349–52.
    1. Kilbourne AM, Reynolds CF, 3, Good CB, et al. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005;13:202–10.
    1. Kim YS, Sunwoo S, Lee HR, et al. Determinants of non-compliance with lipid-lowering therapy in hyperlipidemic patients. Pharmacoepidemiol Drug Saf. 2002;11:593–600.
    1. Kiortsis DN, Giral P, Bruckert E, et al. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. J Clin Pharm Ther. 2000;25:445–51.
    1. Krousel-Wood MA, Thomas S, Muntner P, et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357–62.
    1. Kyngas HA. Compliance of adolescents with asthma. Nurs Health Sci. 1999;1:195–202.
    1. Kyngas H, Lahdenpera T. Compliance of patients with hypertension and associated factors. J Ad Nurs. 1999;29:832–9.
    1. Kyngas H. Predictors of good compliance in adolescents with epilepsy. Seizure. 2001;10:549–53.
    1. Kyngas H, Rissanen M. Support as a crucial predictor of good compliance of adolescents with a chronic disease. J Clin Nurs. 2001;10:767–74.
    1. Lacasse Y, Archibald H, Ernst P, et al. Patterns and determinants of compliance with inhaled steroids in adults with asthma. Can Respir J. 2005;12:211–7.
    1. Lawson VL, Lyne PA, Harvey JN, et al. Understanding why people with type 1 diabetes do not attend for specialist advice: a qualitative analysis of the views of people with insulin-dependent diabetes who do not attend diabetes clinic. J Health Psychol. 2005;10:409–23.
    1. Leggat JE, Jr, Orzol SM, Hulbert-Shearon TE, et al. Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis. 1998;32:139–45.
    1. Lertmaharit S, Kamol-Ratankul P, Sawert H, et al. Factors associated with compliance among tuberculosis patients in Thailand. J Med Assoc Thai. 2005;88(Suppl 4):S149–56.
    1. Liam CK, Lim KH, Wong CM, et al. Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance. Int J Tuberc Lung Dis. 1999;3:300–9.
    1. Lim TO, Ngah BA. The Mentakab hypertension study project. Part II – why do hypertensives drop out of treatment? Singapore Med J. 1991;32:249–51.
    1. Lim TO, Ngah BA, Rahman RA, et al. The Mentakab hypertension study project Part V – Drug compliance in hypertensive patients. Singapore Med J. 1992;33:63–6.
    1. Lindberg M, Ekstrom T, Moller M, et al. Asthma care and factors affecting medication compliance: the patient’s point of view. Int J Qual Health Care. 2001;13:375–83.
    1. Linden M, Gothe H, Dittmann RW, et al. Early termination of antidepressant drug treatment. J Clin Psychopharmacol. 2000;20:523–30.
    1. Loffler W, Kilian R, Toumi M, et al. Schizophrenic patients’ subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry. 2003;36:105–12.
    1. Loong TW. Primary non-compliance in a Singapore polyclinic. Singapore Med J. 1999;40:691–3.
    1. Lorenc L, Branthwaite A. Are older adults less compliant with prescribed medication than younger adults? Br J Clin Psychol. 1993;32:485–92.
    1. Matthews D, Hingson R. Improving patient compliance: a guide for physicians. Med Clin North Am. 1977;61:879–89.
    1. McLane CG, Zyzanski SJ, Flocke SA. Factors associated with medication noncompliance in rural elderly hypertensive patients. Am J Hypertens. 1995;8:206–9.
    1. Menzies R, Rocher I, Vissandjee B. Factors associated with compliance in treatment of tuberculosis. Tuber Lung Dis. 1993;74:32–7.
    1. Milas NC, Nowalk MP, Akpele L, et al. Factors associated with adherence to the dietary protein intervention in the Modification of Diet in Renal Disease Study. J Am Diet Assoc. 1995;95:1295–300.
    1. Mishra P, Hansen EH, Sabroe S, et al. Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis. 2005;9:1134–9.
    1. Monane M, Bohn RL, Gurwitz JH, et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996;86:1805–8.
    1. Moore PJ, Sickel AE, Malat J, et al. Psychosocial factors in medical and psychological treatment avoidance: the role of the doctor-patient relationship. J Health Psychol. 2004;9:421–33.
    1. Murray MD, Darnell J, Weinberger M, et al. Factors contributing to medication noncompliance in elderly public housing tenants. Drug Intell Clin Pharm. 1986;20:146–52.
    1. Neal RD, Hussain-Gambles M, Allgar VL, et al. Reasons for and consequences of missed appointments in general practice in the UK: questionnaire survey and prospective review of medical records. BMC Fam Pract. 2005;6:47.
    1. Neeleman J, Mikhail WI. A case control study of GP and patient-related variables associated with nonattendance at new psychiatric outpatient appointments. J Mental Health. 1997;6:301–6.
    1. Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc. 2000;40:475–85.
    1. Nikolaus T, Kruse W, Bach M, et al. Elderly patients’ problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol. 1996;49:255–9.
    1. Norman SA, Marconi KM, Schezel GW, et al. Beliefs, social normative influences, and compliance with antihypertensive medication. Am J Prev Med. 1985;1:10–7.
    1. O’Donoghue MN. Compliance with antibiotics. Cutis. 2004;73(Suppl 5):30–2.
    1. Okuno J, Yanagi H, Tomura S, et al. Compliance and medication knowledge among elderly Japanese home-care recipients. Eur J Clin Pharmacol. 1999;55:145–9.
    1. Okuno J, Yanagi H, Tomura S. Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur J Clin Pharmacol. 2001;57:589–94.
    1. Olubodun JOB, Falase AO, Cole TO. Drug compliance in hypertensive Nigerians with and without heart failure. Int J Cardiol. 1990;27:229–34.
    1. Opolka JL, Rascati KL, Brown CM, et al. Role of ethnicity in predicting antipsychotic medication adherence. Ann Pharmacother. 2003;37:625–30.
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.
    1. Oxford advanced learner’s dictionary of current English. 7. Oxford: Oxford University Press; 2005. p. 296. compliance.
    1. Patal RP, Taylor SD. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother. 2002;36:40–5.
    1. Ponnusankar S, Surulivelrajan M, Anandamoorthy N, et al. Assessment of impact of medication counseling on patients’ medication knowledge and compliance in an outpatient clinic in South India. Patient Educ Couns. 2004;54:55–60.
    1. Raiz LR, Kilty KM, Henry ML. Medication compliance following renal transplantation. Transplantation. 1999;68:51–5.
    1. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005;118:27s–34s.
    1. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15:175–83.
    1. Roter DL, Hall JA. Why physician gender matters in shaping the physician-patient relationship. J Womens Health. 1998;7:1093–7.
    1. Sabaté E, editor. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
    1. Sackett DL. Introduction. In: Sackett DL, Haynes RB, editors. Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press; 1976. pp. 1–6.
    1. Sackett DL, Haynes RB, Gibson ES, et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205–7.
    1. Sanson-Fisher R, Bowman J, Armstrong S. Factors affecting nonadherence with antibiotics. Diagn Microbiol Infect Dis. 1992;15:103S–109S.
    1. Schweizer RT, Rovelli M, Palmeri D, et al. Noncompliance in organ transplant recipients. Transplantation. 1990;49:374–7.
    1. Segador J, Gil-Guillen VF, Orozco D, et al. The effect of written information on adherence to antibiotic treatment in acute sore throat. Int J Antimicrob Agents. 2005;26:56–61.
    1. Senior V, Marteau TM, Weinman J. Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions. Cardiovasc Drugs Ther. 2004;18:475–81.
    1. Seo MA, Min SK. Development of a structural model explaining medication compliance of persons with schizophrenia. Yonsei Med J. 2005;46:331–40.
    1. Shaw E, Anderson JG, Maloney M, et al. Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm. 1995;30:201–3. 206–7.
    1. Sharkness CM, Snow DA. The patient’s view of hypertension and compliance. Am J Prev Med. 1992;8:141–6.
    1. Shea S, Misra D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82:1607–12.
    1. Siegal B, Greenstein SJ. Compliance and noncompliance in kidney transplant patients: cues for transplant coordinators. Transpl Coord. 1999;9:104–8.
    1. Sirey JA, Bruce ML, Alexopoulos GS, et al. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv. 2001;52:1615–20.
    1. Sleath B, Wurst K, Lowery T. Drug information sources and antidepressant adherence. Community Ment Health J. 2003;39:359–68.
    1. Sloan JP, Sloan MC. An assessment of default and non-compliance in tuberculosis control in Pakistan. Trans R Soc Trop Med Hyg. 1981;75:717–8.
    1. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–30.
    1. Spagnoli A, Ostino G, Borga AD, et al. Drug compliance and unreported drugs in the elderly. J Am Geriatr Soc. 1989;37:619–24.
    1. Spikmans FJ, Brug J, Doven MM, et al. Why do diabetic patients not attend appointments with their dietitian? J Hum Nutr Diet. 2003;16:151–8.
    1. Stanton AL. Determinants of adherence to medical regimens by hypertensive patients. J Behav Med. 1987;10:377–94.
    1. Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am. 1989;73:1551–63.
    1. Stilley CS, Sereika S, Muldoon MF, et al. Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Ann Behav Med. 2004;27:117–24.
    1. Stromberg A, Brostrom A, Dahlstrom U, et al. Factors influencing patient compliance with therapeutic regimens in chronic heart failure: A critical incident technique analysis. Heart Lung. 1999;28:334–41.
    1. Sung JC, Nichol MB, Venturini F, et al. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care. 1998;4:1421–30.
    1. Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv. 2001;52:805–11.
    1. Swett C, Jr, Noones J. Factors associated with premature termination from outpatient treatment. Hosp Community Psychiatry. 1989;40:947–51.
    1. Tebbi CK, Cummings KM, Zevon MA, et al. Compliance of pediatric and adolescent cancer patients. Cancer. 1986;58:1179–84.
    1. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer. 1993;71:3441–9.
    1. Thomas LK, Sargent RG, Michels PC, et al. Identification of the factors associated with compliance to therapeutic diets in older adults with end stage renal disease. J Ren Nutr. 2001;11:80–9.
    1. Turner J, Wright E, Mendella L, et al. Predictors of patient adherence to long-term home nebulizer therapy for COPD. Chest. 1995;108:394–400.
    1. Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research A comprehensive review. J Clin Pharm Therap. 2001;26:331–42.
    1. Vic SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303–12.
    1. Viller F, Guillemin F, Briancon S, et al. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol. 1999;26:2114–22.
    1. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ. 2004;30:112–25.
    1. Vlasnik JJ, Aliotta SL, DeLor B. Medication adherence: factors influencing compliance with prescribed medication plans. Case Manager. 2005;16:47–51.
    1. Voils CI, Steffens DC, Flint EP, et al. Social support and locus of control as predictors of adherence to antidepressant medication in an elderly population. Am J Geriatr Psychiatry. 2005;13:157–65.
    1. Wai CT, Wong ML, Ng S, et al. Utility of the Health Belief Model in predicting compliance of screening in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2005;21:1255–62.
    1. Wild MR, Engleman HM, Douglas NJ, et al. Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J. 2004;24:461–5.
    1. Yavuz A, Tuncer M, Erdogan O, et al. Is there any effect of compliance on clinical parameters of renal transplant recipients? Transplant Proc. 2004;36:120–1.
    1. Yu YF, Nichol MB, Yu AP, et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California medicaid program. Value Health. 2005;8:495–505.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する